You may need the Japanese encephalitis vaccine if you are travelling to rural or agricultural areas of Asia where the Japanese encephalitis virus is endemic, particularly if your trip involves spending time outdoors during the evening or night, when the mosquitoes that transmit the virus are most active. The vaccine is strongly recommended for travellers spending a month or more in endemic areas during the transmission season, as well as for shorter trips where the itinerary involves high-risk activities such as cycling, camping, hiking, or working in agricultural settings. Japanese encephalitis is a rare disease in travellers overall, but it is the leading cause of viral encephalitis in Asia, and because there is no specific antiviral treatment once infection has occurred, prevention through vaccination is the only reliable means of protection. Perfect Meds pharmacists are GPhC-regulated and experienced in assessing individual travel itineraries and risk profiles, providing expert, personalised advice on whether the Japanese encephalitis vaccine is appropriate for your specific trip in a single convenient appointment.
Book now to arrange your Japanese encephalitis vaccination consultation at Perfect Meds.
The Japanese encephalitis vaccine is recommended for travellers visiting rural or agricultural areas of Asia for a month or more, and for shorter trips where the itinerary involves outdoor activities in high-risk areas during the transmission season. The vaccine course consists of two doses given 28 days apart, with a booster recommended one year later for those who remain at ongoing risk. The only Japanese encephalitis vaccine currently licensed in the UK is Ixiaro, which is suitable for adults and children aged two months and over. Vaccination should ideally be completed at least one week before potential exposure, so early booking is essential — a pharmacist at Perfect Meds can assess your risk and administer the vaccine in a single appointment.
What is Japanese Encephalitis?
Japanese encephalitis (JE) is a serious viral infection of the brain caused by the Japanese encephalitis virus (JEV), a member of the Flavivirus family — the same family that includes dengue, Zika, and yellow fever viruses. The virus is transmitted to humans through the bites of infected Culex mosquitoes, particularly Culex tritaeniorhynchus, which breed in rice paddies and other irrigated agricultural environments and feed predominantly during the evening and night hours. Despite its name, Japanese encephalitis is now rare in Japan due to widespread vaccination programmes, and the highest burden of disease is found in South and Southeast Asia, East Asia, and parts of the Western Pacific region.
Japanese encephalitis is the leading cause of viral encephalitis in Asia, with an estimated 68,000 clinical cases occurring each year according to the WHO Japanese Encephalitis Fact Sheet, resulting in approximately 13,400 to 20,400 deaths annually. The true incidence is likely to be significantly higher, as many cases go undiagnosed or unreported in resource-limited settings. Whilst the overall risk to individual travellers is low — estimated at less than one case per million travellers to Asia — the consequences of infection are severe and the disease carries a high risk of permanent neurological disability in survivors.
Japanese encephalitis virus circulates in an enzootic transmission cycle primarily involving pigs as amplifying hosts and wading birds as reservoir hosts, with humans being incidental dead-end hosts who do not contribute to ongoing transmission. This means that the risk of JE infection is most closely associated with proximity to pig farming and rice cultivation, and travellers who avoid these rural and agricultural environments are at substantially lower risk than those who spend extended time in them.
Where is Japanese Encephalitis Found?
Japanese encephalitis is endemic across a wide geographic area spanning much of Asia and the Western Pacific. Before deciding whether vaccination is appropriate for your trip, it is important to understand which specific countries and regions carry a meaningful risk of Japanese encephalitis exposure.
–> South Asia: India (particularly rural areas), Nepal, Sri Lanka, Bangladesh, and Pakistan (limited areas).
–> Southeast Asia: Thailand, Vietnam, Cambodia, Laos, Myanmar, Malaysia, Indonesia, the Philippines, and Timor-Leste.
–> East Asia: China, Japan (residual risk in rural areas), South Korea, and Taiwan.
–> The Western Pacific: Papua New Guinea, parts of Australia (Torres Strait Islands and far north Queensland), and various Pacific Island territories.
The transmission season varies by region and is closely linked to the monsoon season and patterns of rice cultivation and pig farming. In tropical regions near the equator, transmission can occur year-round. In more temperate regions such as northern China, Korea, Japan, and Nepal, transmission is seasonal — typically occurring between June and October. In areas such as South Asia and Southeast Asia, transmission generally peaks during and after the rainy season. Transmission can occur in both rural and suburban settings, though the risk is considerably lower in urban environments without proximity to agricultural land.
Who Should Get the Japanese Encephalitis Vaccine?
The decision to vaccinate against Japanese encephalitis requires a careful assessment of the individual traveller’s risk, based on their specific destination, the time of year they are travelling, the duration of their stay, and the activities they are planning to undertake. Current UKHSA and TravelHealthPro guidance provides a framework for assessing JE risk, but the final decision should always be made in consultation with a qualified travel health professional who can interpret that framework in the context of the individual’s itinerary.
Travellers for Whom the Japanese Encephalitis Vaccine is Recommended
–> Travellers spending a month or more in JE-endemic rural or agricultural areas of Asia during the transmission season, regardless of the specific activities planned.
–> Shorter-stay travellers whose itinerary involves significant outdoor exposure in rural or agricultural areas, including cyclists, hikers, campers, and those undertaking field research or wildlife observation.
–> Travellers working or volunteering in agricultural, veterinary, or field research settings in endemic areas, particularly those involving proximity to pigs or wading birds.
–> Travellers making repeated trips to JE-endemic regions who may accumulate significant cumulative exposure over time.
–> Expatriates and long-term residents living in JE-endemic areas of Asia.
–> Travellers visiting known outbreak areas, regardless of trip duration, where the risk may be temporarily elevated above baseline.
–> Laboratory workers who handle live JE virus as part of their professional work.
Travellers who are spending their entire trip in urban environments in JE-endemic countries — such as those visiting major city centres for business or leisure without venturing into rural areas — are generally considered to be at very low risk and vaccination is not routinely recommended for them. However, if any part of an urban trip involves excursions to rural or agricultural areas, even for a day, the risk assessment changes and vaccination may become appropriate. A pharmacist at Perfect Meds can review your full itinerary and provide a clear, evidence-based recommendation.
Travellers heading to a high-risk destination and unsure whether the Japanese encephalitis vaccine is right for their trip should seek expert advice before it is too late to complete the course. Contact us to get a personalised travel health assessment at Perfect Meds today.
The Ixiaro Vaccine — The Only Licensed Japanese Encephalitis Vaccine in the UK
The only Japanese encephalitis vaccine currently licensed for use in the UK is Ixiaro (manufactured by Valneva), an inactivated Vero cell-derived vaccine that has replaced the older mouse brain-derived vaccines previously used in some countries. Ixiaro contains inactivated Japanese encephalitis virus (SA14-14-2 strain) adsorbed onto aluminium hydroxide adjuvant. Because it is an inactivated vaccine, it does not contain live virus and cannot cause Japanese encephalitis infection, making it safe for use in immunocompromised individuals, though the immune response may be reduced in this group.
Ixiaro is licensed for use in adults and children aged two months and over, though the dosing may differ slightly between age groups. The vaccine has an excellent safety record from clinical trials and post-marketing surveillance, and is the international standard for Japanese encephalitis prevention in travellers from non-endemic countries. It is important to note that Ixiaro is not available on the NHS for travel purposes and must be obtained through a private travel clinic or registered pharmacy such as Perfect Meds.
The Japanese Encephalitis Vaccination Schedule
The standard Japanese encephalitis vaccination schedule with Ixiaro for adults and children aged three years and over consists of two doses given 28 days apart. Ideally, the course should be completed at least one week before potential exposure to allow the immune system to develop a full protective response. For adults aged 18 to 65 who are travelling at short notice, an accelerated schedule delivering both doses seven days apart is available and has been shown to produce comparable antibody levels to the standard 28-day schedule, providing a practical option for those who have left their travel health preparations until close to their departure date. It is important to note that the accelerated schedule is licensed for adults aged 18 to 65 only — use outside this age range is off-label and requires specialist assessment.
For children aged two months to less than three years, the dosing volume is halved but the schedule remains the same — two doses 28 days apart. A booster dose is recommended for those who remain at ongoing risk of JE exposure. Current UKHSA guidance recommends a booster dose one year after the primary two-dose course for those who continue to be at risk, with further boosters every three years thereafter for continued ongoing exposure. The table below provides a clear summary of the Ixiaro vaccination schedule, booster recommendations, and key suitability information.
| Schedule | Dose Timing | Age Group | Booster | Notes |
|---|---|---|---|---|
| Standard | 2 doses, 28 days apart | Adults and children aged 3 years and over | At 1 year if at ongoing risk, then every 3 years | Complete at least 1 week before travel |
| Accelerated | 2 doses, 7 days apart | Adults aged 18 to 65 only (licensed) | At 1 year if at ongoing risk, then every 3 years | Use outside age range is off-label and requires specialist assessment |
| Paediatric | 2 doses, 28 days apart (half dose volume) | Children aged 2 months to under 3 years | At 1 year if at ongoing risk, then every 3 years | Half the adult dose volume per injection |
| Booster | Single dose | All ages (following completed primary course) | Every 3 years for continued ongoing exposure | Recommended 1 year after primary course if still at risk |
How Long Does the Japanese Encephalitis Vaccine Last?
Following completion of the standard two-dose primary course of Ixiaro, protection is considered to be established within one week of the second dose for the vast majority of recipients. For travellers who complete the course and then return to the UK without further exposure risk, the duration of protection from the primary course alone has not been fully defined by long-term studies — however, the clinical trial data and post-marketing experience support meaningful protection for at least twelve to twenty-four months following the primary course.
For those who remain at ongoing risk — including frequent travellers to JE-endemic regions, expatriates, and those with occupational exposure — current UKHSA guidance recommends a booster dose one year after the primary course, with further boosters every three years thereafter for continued ongoing exposure. For individuals who completed a primary course more than a year ago and are returning to a JE-endemic area, a single booster dose is recommended rather than repeating the full two-dose course. A pharmacist at Perfect Meds can review your vaccination history and advise on whether a booster is needed ahead of your next trip, or whether the full primary course needs to be repeated.
Symptoms and Clinical Features of Japanese Encephalitis
Travellers heading to high-risk regions should familiarise themselves with the symptoms of Japanese encephalitis, as early recognition and prompt medical attention are among the most important factors in determining how the illness progresses. The vast majority of people infected with the Japanese encephalitis virus — an estimated more than 99% — experience no symptoms at all or only mild, non-specific illness. This high proportion of subclinical infection is one of the reasons that the true incidence of JEV infection is almost certainly much higher than the reported number of clinical cases suggests.
In the small proportion of infected individuals who develop clinical disease, Japanese encephalitis typically presents with a sudden onset of high fever, headache, vomiting, and altered mental status. In severe cases, the illness progresses rapidly to encephalitis — inflammation of the brain — with features including seizures, focal neurological deficits, movement disorders, and coma. The case fatality rate in clinical cases is estimated at 20 to 30%, and among survivors, 30 to 50% are left with significant long-term neurological or psychiatric sequelae including cognitive impairment, movement disorders, and behavioural changes. These statistics underline why prevention through vaccination is so important for those at meaningful risk of exposure.
Japanese encephalitis is just one of several serious diseases that travellers to Asia and other high-risk regions may need to protect themselves against, and understanding your full vaccination requirements before you depart is essential for a safe and well-prepared trip. Enter your destination below to get an instant overview of the travel vaccinations that may be recommended for your itinerary, including whether the Japanese encephalitis vaccine should form part of your pre-travel health plan:
Japanese Encephalitis Vaccine Safety and Side Effects
Ixiaro has been evaluated extensively in clinical trials and through post-marketing surveillance and has a well-established safety profile. The vaccine is generally very well tolerated across all age groups for which it is licensed, including infants and young children. The absence of nervous system tissue derived from mouse brains that was used in older JE vaccine formulations means that the neurological adverse events associated with those earlier vaccines are not a concern with Ixiaro.
Common and Less Common Side Effects of Ixiaro
–> Soreness, tenderness, redness, or mild swelling at the injection site — the most frequently reported reaction, occurring in a significant proportion of recipients and typically resolving within two to three days.
–> Headache and fatigue following vaccination, reported by a proportion of adult recipients and usually short-lived.
–> Mild fever, muscle aches, or flu-like symptoms in a smaller proportion of recipients, particularly following the first dose.
–> In children, irritability, crying, and mild gastrointestinal symptoms such as loss of appetite are among the most commonly reported reactions following vaccination.
–> Serious allergic reactions (anaphylaxis) are extremely rare — recipients should remain at the vaccination centre for at least 15 minutes after each dose so that any immediate reactions can be identified and managed promptly.
The Ixiaro vaccine has not been associated with any serious long-term adverse effects in the clinical trial data or post-marketing surveillance conducted to date. The vaccine is considered safe for use in immunocompromised individuals, though the immune response may be reduced, and in older adults, though the standard dosing schedule applies to all adults regardless of age. Pregnant women should discuss the risk-benefit assessment of JE vaccination with a healthcare professional, as data on the use of Ixiaro in pregnancy is limited — however, in situations where the risk of JE exposure during pregnancy is considered significant, vaccination may be recommended.
Anyone planning a trip to a JE-endemic region should ensure their vaccination is sorted well ahead of their departure date to allow sufficient time for the full two-dose course to be completed. Call us to book a consultation and travel with complete confidence.
Mosquito Bite Prevention — An Essential for Travellers
Whilst the Japanese encephalitis vaccine is highly effective at reducing the risk of clinical JE disease, vaccination alone is not sufficient protection for travellers in high-risk environments — particularly given that the same mosquitoes that transmit JEV can also transmit other diseases including dengue fever, chikungunya, and malaria, for which there is no single comprehensive vaccine. Mosquito bite prevention measures are therefore an essential and non-negotiable component of any travel health strategy for those visiting JE-endemic regions.
The Culex mosquitoes responsible for JE transmission are most active during the evening and night hours, from dusk to dawn. This biting pattern means that the risk of JEV transmission is highest during outdoor activities in the evenings, sleeping in unscreened or unprotected accommodation, and early morning outdoor exposure. Effective bite prevention during these peak hours is critical for minimising the risk of JE and other vector-borne diseases.
Mosquito Bite Prevention Measures for JE-Endemic Regions
–> Apply a DEET-based insect repellent (at least 50% DEET concentration) to all exposed skin during peak biting hours — reapply regularly, especially after sweating or swimming.
–> Wear loose-fitting, light-coloured, long-sleeved clothing and long trousers during the evening and night to minimise exposed skin.
–> Sleep under a permethrin-impregnated mosquito net, particularly in accommodation that does not have adequate screening or air conditioning.
–> Use insecticide sprays, coils, or plug-in devices in sleeping areas to reduce mosquito presence indoors.
–> Avoid outdoor activities in rural or agricultural areas during peak biting times where possible, particularly near rice paddies, pig farms, or areas of standing water.
–> Treat clothing and outdoor equipment with permethrin for additional protection during extended outdoor activities.
Japanese Encephalitis and Children
Children travelling with their families to JE-endemic regions deserve particular attention in any travel health risk assessment. Ixiaro is licensed for use in children from two months of age, making it suitable for most paediatric travellers to high-risk destinations. Children may be at heightened risk of JE exposure due to their tendency to play outdoors during the evening, their generally closer contact with animals and the natural environment, and their potentially reduced ability to comply consistently with personal protective measures such as insect repellent application.
The risk-benefit assessment for vaccinating children against JE follows the same principles as for adults — the duration of stay, the specific areas to be visited, the planned activities, and the time of year are all relevant factors. Vaccination of all eligible family members, including children, is strongly advisable for any family trip that involves extended rural stays, outdoor activities in endemic areas, or travel at a time when transmission risk is at its highest. Parents should discuss the full travel itinerary with a travel health professional well in advance of departure to allow sufficient time to complete the two-dose course before travel.
Where Can You Get the Japanese Encephalitis Vaccine in the UK?
The Japanese encephalitis vaccine (Ixiaro) is not available on the NHS for travel purposes and must be obtained through a private travel clinic or registered pharmacy. The cost of the vaccine varies between providers, and the full two-dose primary course represents a meaningful but important investment in travel health protection for those at genuine risk. Given that the two-dose course needs to be completed at least one week before travel on the standard schedule — or at least eight days before on the accelerated schedule — early booking is essential to ensure that the course can be completed in time.
At Perfect Meds, we offer the Japanese encephalitis vaccine as part of a comprehensive travel health consultation service that assesses your complete itinerary and ensures you receive all the vaccinations and medications appropriate for your trip. Our GPhC-regulated pharmacists can administer both doses of the Ixiaro vaccine, advise on mosquito bite prevention, and provide guidance on all other relevant travel health measures for your destination — all in a straightforward, convenient appointment process.
Frequently Asked Questions
Whether you are planning your first trip to Asia or want to check whether your existing Japanese encephalitis vaccination is still current, these answers to the most common questions will help you make a confident and well-informed decision about your travel health.
Is the Japanese encephalitis vaccine suitable for everyone?
Ixiaro is suitable for most adults and children aged two months and over, including immunocompromised individuals and older adults. However, those with a known severe allergy to any component of the vaccine, including alum and protamine sulphate, should discuss their suitability for vaccination with a healthcare professional before proceeding.
Do I need the Japanese encephalitis vaccine for a city break in Asia?
Travellers spending their entire trip in urban environments without visiting rural or agricultural areas are generally considered to be at very low risk and vaccination is not routinely recommended. However, if any part of the trip involves excursions to rural areas, outdoor activities, or stays near rice paddies or pig farming environments, the risk assessment changes and vaccination may be appropriate — a pharmacist can advise based on your specific itinerary.
Can I have the Japanese encephalitis vaccine at the same time as other travel vaccines?
Yes — Ixiaro can be administered alongside most other travel vaccines, including hepatitis A, hepatitis B, typhoid, rabies, and yellow fever, without any meaningful reduction in efficacy or increased risk of side effects. Combining multiple vaccinations in a single travel health appointment is not only safe but practical and is something our pharmacists at Perfect Meds routinely facilitate.
Is the Japanese encephalitis vaccine safe during pregnancy?
Data on the use of Ixiaro during pregnancy is limited, and the vaccine should generally be avoided unless the risk of Japanese encephalitis exposure is considered to outweigh any theoretical risk of vaccination. Pregnant women who must travel to high-risk JE-endemic areas should discuss the risk-benefit assessment in detail with their GP or a travel health professional before making a decision about vaccination.
How soon before travel should I start the Japanese encephalitis vaccine course?
The standard two-dose course should be started at least 29 days before travel to allow both doses to be given 28 days apart and for immunity to develop fully before departure. For adults aged 18 to 65, the accelerated seven-day schedule is licensed and provides a minimum lead time of eight days before travel — though earlier booking is always preferable to ensure flexibility if appointments are limited.
What should I do if I missed my second dose of the Japanese encephalitis vaccine?
The second dose of Ixiaro should ideally be given 28 days after the first and no later than 60 days to remain within the licensed schedule — if a longer interval has elapsed, a pharmacist or GP should be consulted about whether to restart the course. You should contact your vaccination provider as soon as possible rather than assuming the missed dose can simply be given at any later date, as proceeding outside the licensed interval requires clinical assessment.
Get Your Japanese Encephalitis Vaccination Sorted Today
Japanese encephalitis is a rare but devastating disease, and for travellers visiting the rural and agricultural regions of Asia where it circulates, the Japanese encephalitis vaccine is one of the most important and impactful travel health decisions they can make. The two-dose Ixiaro course is safe, effective, and well tolerated across all eligible age groups, and when combined with consistent mosquito bite prevention measures, it gives travellers visiting high-risk environments the best possible protection against a disease for which there is no specific treatment once infection has taken hold.
At Perfect Meds, our GPhC-regulated pharmacists are here to make the process of getting vaccinated against Japanese encephalitis straightforward, accessible, and expertly guided. Whether you need a full primary course ahead of an upcoming trip, a booster following a previous course, or simply a comprehensive travel health review that covers all the vaccinations your itinerary requires, we provide personalised, evidence-based advice in fast, convenient appointments. Book now to arrange your Japanese encephalitis vaccination at Perfect Meds and set off on your Asian adventure fully protected and completely prepared.
Medical Disclaimer: The information provided in this article is intended for general informational purposes only and does not constitute medical advice. Individual circumstances vary, and you should always speak to a qualified medical professional or pharmacist before starting any vaccination, treatment, or health programme. If you have any concerns about your health or suitability for any vaccine, please consult your GP or a registered healthcare provider before proceeding.
